These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 8528833

  • 1. Torsemide: a new loop diuretic.
    Fowler SF, Murray KM.
    Am J Health Syst Pharm; 1995 Aug 15; 52(16):1771-80; quiz 1814-5. PubMed ID: 8528833
    [Abstract] [Full Text] [Related]

  • 2. Torsemide: a pyridine-sulfonylurea loop diuretic.
    Blose JS, Adams KF, Patterson JH.
    Ann Pharmacother; 1995 Apr 15; 29(4):396-402. PubMed ID: 7633019
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC.
    Drug Saf; 1996 Feb 15; 14(2):104-20. PubMed ID: 8852525
    [Abstract] [Full Text] [Related]

  • 4. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA, Buckley MM.
    Drugs; 1991 Jan 15; 41(1):81-103. PubMed ID: 1706990
    [Abstract] [Full Text] [Related]

  • 5. Torsemide (Demadex)--a new loop diuretic.
    Med Lett Drugs Ther; 1994 Aug 19; 36(929):73-4. PubMed ID: 8047047
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H, Ohtaki Y.
    Nihon Yakurigaku Zasshi; 2001 Aug 19; 118(2):97-105. PubMed ID: 11530685
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The pharmacodynamics of torsemide in patients with congestive heart failure.
    Vargo D, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC.
    Clin Pharmacol Ther; 1994 Jul 19; 56(1):48-54. PubMed ID: 8033494
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure.
    Kramer WG, Smith WB, Ferguson J, Serpas T, Grant AG, Black PK, Brater DC.
    J Clin Pharmacol; 1996 Mar 19; 36(3):265-70. PubMed ID: 8690821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA, Peddle GD, Reynolds CA, Singletary GE.
    J Vet Cardiol; 2011 Dec 19; 13(4):287-92. PubMed ID: 22030290
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Clissold SP, Brogden RN.
    Drugs; 1985 Jun 19; 29(6):489-530. PubMed ID: 3891305
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T, Krämer B, Müller GA.
    Drugs; 1991 Jun 19; 41 Suppl 3():69-79. PubMed ID: 1712716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.